Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7876
-0.0074 (-0.93%)
At close: Sep 12, 2025, 4:00 PM EDT
0.7899
+0.0023 (0.29%)
After-hours: Sep 12, 2025, 7:55 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $16.59 million as of September 12, 2025. Its market cap has decreased by -49.33% in one year.
Market Cap
16.59M
Enterprise Value
7.39M
1-Year Change
-49.33%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $16.59M, a decrease of -90.38%. That is a compound annual growth rate of -40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 16.59M | -35.38% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |